Infinity Pharmaceuticals, Inc.
INFIQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -9.96M | -11.05M | -9.23M | -10.72M | -11.99M |
| Total Depreciation and Amortization | 106.00K | 105.00K | 106.00K | 111.00K | 120.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 593.00K | 1.21M | 779.00K | 610.00K | 549.00K |
| Change in Net Operating Assets | 1.25M | -2.85M | -555.00K | 595.00K | 722.00K |
| Cash from Operations | -8.01M | -12.58M | -8.90M | -9.40M | -10.60M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 10.73M | 3.28M |
| Cash from Investing | -- | -- | 0.00 | 10.73M | 3.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.00K | -- | 31.00K | 14.00K | 28.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.00K | -- | 31.00K | 14.00K | 28.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.99M | -12.58M | -8.87M | 1.34M | -7.29M |